Compartmentalized intrathecal immunoglobulin synthesis during HIV infection - A model of chronic CNS inflammation?

Journal of Neuroimmunology

Volumn 285, Issue , 2015, Pages 41-52

  Bonnan, Mickael ^a   Barroso, Bruno ^a   Demasles, Stéphanie ^a   Krim, Elsa ^a   Marasescu, Raluca ^a   Miquel, Marie ^a  

^a Hospital F Mitterrand   (France)

Author keywords

Cerebrospinal fluid; Encephalopathy; Human immunodeficiency virus; Immunoglobulins; Intrathecal synthesis

Indexed keywords

CYTOKINE; OLIGOCLONAL BAND; VIRUS ANTIGEN; IMMUNOGLOBULIN G;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CENTRAL NERVOUS SYSTEM PARENCHYMA; CEREBROSPINAL FLUID; CHRONIC CENTRAL NERVOUS SYSTEM INFLAMMATION; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS INFECTION; ANIMAL; BIOSYNTHESIS; CHRONIC DISEASE; IMMUNOLOGY; INFLAMMATION; METABOLISM; SPINAL CORD; VIROLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM INFECTIONS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; SPINAL CORD;

EID: 84943234416     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.05.015     Document Type: Review

References (160)

1. Abdulle S., Hagberg L., Svennerholm B., Fuchs D., Gisslen M. Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection. AIDS 2002, 16:2145-2149.
2. Abdulle S., Hagberg L., Gisslen M. Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients. HIV Med. 2005, 6:164-169.
3. Abdulle S., Mellgren A., Brew B.J., Cinque P., Hagberg L., Price R.W., et al. CSF neurofilament protein (NFL) - a marker of active HIV-related neurodegeneration. J. Neurol. 2007, 254:1026-1032.
4. Amadori A., De Rossi A., Gallo P., Tavolato B., Chieco-Bianchi L. Cerebrospinal fluid lymphocytes from HIV-infected patients synthesize HIV-specific antibody in vitro. J. Neuroimmunol. 1988, 18:181-186.
5. Amanna I.J., Slifka M.K. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol. Rev. 2010, 236:125-138.
6. Andersson M.A., Bergstrom T.B., Blomstrand C., Hermodsson S.H., Hakansson C., Lowhagen G.B. Increasing intrathecal lymphocytosis and immunoglobulin G production in neurologically asymptomatic HIV-1 infection. J. Neuroimmunol. 1988, 19:291-304.
7. Anthony I.C., Crawford D.H., Bell J.E. B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas. Brain 2003, 126:1058-1067.
8. Antinori A., Arendt G., Becker J.T., Brew B.J., Byrd D.A., Cherner M., et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69:1789-1799.
9. Awan F.M., Anjum S., Obaid A., Ali A., Paracha R.Z., Janjua H.A. In-silico analysis of claudin-5 reveals novel putative sites for post-translational modifications: insights into potential molecular determinants of blood-brain barrier breach during HIV-1 infiltration. Infect. Genet. Evol. 2014, 27:355-365.
10. Bachani M., Sacktor N., McArthur J.C., Nath A., Rumbaugh J. Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders. J. Neurovirol. 2013, 19:82-88.
11. Becker J.T., Maruca V., Kingsley L.A., Sanders J.M., Alger J.R., Barker P.B., et al. Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology 2012, 54:113-121.
12. Bednárová J., Stourac P., Adam P. Relevance of immunological variables in neuroborreliosis and multiple sclerosis. Acta Neurol. Scand. 2005, 112:97-102.
13. Bø L., Vedeler C.A., Nyland H.I., Trapp B.D., Mørk S.J. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J. Neuropathol. Exp. Neurol. 2003, 62:723-732.
14. Bonnan M. Does disease-irrelevant intrathecal synthesis in multiple sclerosis make sense in the light of tertiary lymphoid organs?. Front. Neurol. 2014, 5:27.
15. Borges A.S., Figueiredo J.F. Evaluation of intrathecal synthesis of specific IgG antibodies against Toxoplasma gondii in the diagnosis assessment of presumptive toxoplasma encephalitis in AIDS patients. Rev. Soc. Bras. Med. Trop. 2004, 37:480-484.
16. Brecht I., Weissbrich B., Braun J., Toyka K.V., Weishaupt A., Buttmann M. Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis. PLoS One 2012, 7:e40431.
17. Bremell D., Mattsson N., Edsbagge M., Blennow K., Andreasson U., Wikkelso C., et al. Cerebrospinal fluid CXCL13 in lyme neuroborreliosis and asymptomatic HIV infection. BMC Neurol. 2013, 13:2.
18. Buffet R., Agut H., Chieze F., Katlama C., Bolgert F., Devillechabrolle A., et al. Virological markers in the cerebrospinal fluid from HIV-1-infected individuals. AIDS 1991, 5:1419-1424.
19. Bukasa K.S., Sindic C.J., Bodeus M., Burtonboy G., Laterre C., Sonnet J. Anti-HIV antibodies in the CSF of AIDS patients: a serological and immunoblotting study. J. Neurol. Neurosurg. Psychiatry 1988, 51:1063-1068.
20. Calcagno A., Alberione M.C., Romito A., Imperiale D., Ghisetti V., Audagnotto S., et al. Prevalence and predictors of blood-brain barrier damage in the HAART era. J. Neurovirol. 2014, 20:521-525.
21. Campbell J.H., Ratai E.M., Autissier P., Nolan D.J., Tse S., Miller A.D., et al. Anti-alpha4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection. PLoS Pathog. 2014, 10:e1004533.
22. Canestri A., Lescure F.X., Jaureguiberry S., Moulignier A., Amiel C., Marcelin A.G., et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin. Infect. Dis. 2010, 50:773-778.
23. Cepok S., von Geldern G., Nolting T., Grummel V., Srivastava R., Zhou D., et al. Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection. Ann. Neurol. 2007, 62:458-467.
24. Chiang M.C., Dutton R.A., Hayashi K.M., Lopez O.L., Aizenstein H.J., Toga A.W., et al. 3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage 2007, 34:44-60.
25. Chiodi F., Norkrans G., Hagberg L., Sonnerborg A., Gaines H., Froland S., et al. Human immunodeficiency virus infection of the brain. II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation. J. Neurol. Sci. 1988, 87:37-48.
26. Chiodi F., Sonnerborg A., Albert J., Gaines H., Norkrans G., Hagberg L., et al. Human immunodeficiency virus infection of the brain. I. Virus isolation and detection of HIV specific antibodies in the cerebrospinal fluid of patients with varying clinical conditions. J. Neurol. Sci. 1988, 85:245-257.
27. Cinque P., Bestetti A., Marenzi R., Sala S., Gisslen M., Hagberg L., et al. Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection. J. Neuroimmunol. 2005, 168:154-163.
28. Coker W.J., Jeter A., Schade H., Kang Y. Plasma cell disorders in HIV-infected patients: epidemiology and molecular mechanisms. Biomark. Res. 2013, 1:8.
29. Conrad A.J., Chiang E.Y., Andeen L.E., Avolio C., Walker S.M., Baumhefner R.W., et al. Quantitation of intrathecal measles virus IgG antibody synthesis rate: subacute sclerosing panencephalitis and multiple sclerosis. J. Neuroimmunol. 1994, 54:99-108.
30. Contini C., Fainardi E., Cultrera R., Seraceni S., Castellazzi M., Peyron F., et al. Evidence of cerebrospinal fluid free kappa light chains in AIDS patients with Toxoplasma gondii encephalitis. J. Neuroimmunol. 2000, 108:221-226.
31. Dahl V., Peterson J., Fuchs D., Gisslen M., Palmer S., Price R.W. Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10years of suppressive therapy are associated with local immune activation. AIDS 2014, 28:2251-2258.
32. Damas J.K., Landro L., Fevang B., Heggelund L., Froland S.S., Aukrust P. Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy. AIDS 2009, 23:135-138.
33. Davis L.E., Hjelle B.L., Miller V.E., Palmer D.L., Llewellyn A.L., Merlin T.L., et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992, 42:1736-1739.
34. De Gasperi R., Angel M., Sosa G., Patarca R., Battistini S., Lamoreux M.R., et al. Intrathecal synthesis of anti-sulfatide IgG is associated with peripheral nerve disease in acquired immunodeficiency syndrome. AIDS Res. Hum. Retrovir. 1996, 12:205-211.
35. del Bono V., Biselli R., Nisini R., Loomis-Price L.D., Loy A., Lorusso C., et al. Isoelectricfocusing and reverse blotting as a diagnostic tool in pediatric HIV infection. J. Clin. Virol. 1998, 11:203-210.
36. del Palacio M., Alvarez S., Munoz-Fernandez M.A. HIV-1 infection and neurocognitive impairment in the current era. Rev. Med. Virol. 2012, 22:33-45.
37. Doria-Rose N.A., Connors M. Antibody-secreting B cells in HIV infection. Curr. Opin. HIV AIDS 2009, 4:426-430.
38. Dorries R., Watanabe R., Wege H., ter Meulen V. Murine coronavirus-induced encephalomyelitis in rats: analysis of immunoglobulins and virus-specific antibodies in serum and cerebrospinal fluid. J. Neuroimmunol. 1986, 12:131-142.
39. Dorries R., Kaiser R., ter Meulen V. Human immunodeficiency virus infection: affinity-mediated immunoblot detects intrathecal synthesis of oligoclonal IgG specific for individual viral proteins. AIDS Res. Hum. Retrovir. 1989, 5:303-310.
40. Eden A., Price R.W., Spudich S., Fuchs D., Hagberg L., Gisslen M. Immune activation of the central nervous system is still present after >4years of effective highly active antiretroviral therapy. J. Infect. Dis. 2007, 196:1779-1783.
41. Eden A., Fuchs D., Hagberg L., Nilsson S., Spudich S., Svennerholm B., et al. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J. Infect. Dis. 2010, 202:1819-1825.
42. Elovaara I., Iivanainen M., Valle S.L., Suni J., Tervo T., Lahdevirta J. CSF protein and cellular profiles in various stages of HIV infection related to neurological manifestations. J. Neurol. Sci. 1987, 78:331-342.
43. Elovaara I., Seppala I., Poutiainen E., Suni J., Valle S.L. Intrathecal humoral immunologic response in neurologically symptomatic and asymptomatic patients with human immunodeficiency virus infection. Neurology 1988, 38:1451-1456.
44. Elovaara I., Seppala I., Kinnunen E., Laaksovirta H. Increased occurrence of free immunoglobulin light chains in cerebrospinal fluid and serum in human immunodeficiency virus-1 infection. J. Neuroimmunol. 1991, 35:65-77.
45. Elovaara I., Albert P.S., Ranki A., Krohn K., Seppala I. HIV-1 specificity of cerebrospinal fluid and serum IgG, IgM, and IgG1-G4 antibodies in relation to clinical disease. J. Neurol. Sci. 1993, 117:111-119.
46. Elovaara I., Nykyri E., Poutiainen E., Hokkanen L., Raininko R., Suni J. CSF follow-up in HIV-1 infection: intrathecal production of HIV-specific and unspecific IGG, and beta-2-microglobulin increase with duration of HIV-1 infection. Acta Neurol. Scand. 1993, 87:388-396.
47. Emskoetter T., von Laer D., Veismann S., Ermer M. Human immunodeficiency virus (HIV)-specific antibodies, neutralizing activity and antibody-dependent cellular cytotoxicity (ADCC) in the cerebrospinal fluid of HIV-infected patients. J. Neuroimmunol. 1989, 24:61-66.
48. Fagnart O.C., Sindic C.J., Laterre C. Free kappa and lambda light chain levels in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. J. Neuroimmunol. 1988, 19:119-132.
49. Fainardi E., Contini C., Benassi N., Bedetti A., Castellazzi M., Vaghi L., et al. Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders. J. Neuroimmunol. 2001, 119:278-286.
50. Fischer-Smith T., Bell C., Croul S., Lewis M., Rappaport J. Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. J. Neurovirol. 2008, 14:318-326.
51. Gallo P., Piccinno M.G., De Rossi A., Pagni S., Amadori A., Chieco-Bianchi L., et al. Free light chains of immunoglobulins in the cerebrospinal fluid of human immunodeficiency virus type 1-infected patients. J. Neuroimmunol. 1990, 26:229-238.
52. Gisslen M., Fredman P., Norkrans G., Hagberg L. Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type I infection. AIDS Res. Hum. Retrovir. 1996, 12:149-155.
53. Gisslen M., Fuchs D., Svennerholm B., Hagberg L. Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J. Acquir. Immune Defic. Syndr. 1999, 21:271-276.
54. Gisslen M., Lekman A., Fredman P. High levels in serum, but no signs of intrathecal synthesis of anti-sulfatide antibodies in HIV-1 infected individuals with or without central nervous system complications. J. Neuroimmunol. 1999, 94:153-156.
55. Gisslen M., Lekman A., Fredman P. Cerebrospinal fluid antibodies directed against neuron-associated gangliosides in HIV-1 infection. Infection 2000, 28:143-148.
56. Gisslen M., Rosengren L., Hagberg L., Deeks S.G., Price R.W. Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection. AIDS Res. Ther. 2005, 2:6.
57. Gisslen M., Hagberg L., Brew B.J., Cinque P., Price R.W., Rosengren L. Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. J. Infect. Dis. 2007, 195:1774-1778.
58. Gold J., Goldacre R., Maruszak H., Giovannoni G., Yeates D., Goldacre M. HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study. J. Neurol. Neurosurg. Psychiatry 2015, 86:9-12.
59. Gomez A.M., Willcox N., Molenaar P.C., Buurman W., Martinez-Martinez P., De Baets M.H., et al. Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?. Ann. N. Y. Acad. Sci. 2012, 1274:48-59.
60. Gongvatana A., Harezlak J., Buchthal S., Daar E., Schifitto G., Campbell T., et al. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy. J. Neurovirol. 2013, 19:209-218.
61. Gorantla S., Poluektova L., Gendelman H.E. Rodent models for HIV-associated neurocognitive disorders. Trends Neurosci. 2012, 35:197-208.
62. Goswami K.K., Kaye S., Miller R., McAllister R., Tedder R. Intrathecal IgG synthesis and specificity of oligoclonal IgG in patients infected with HIV-1 do not correlate with CNS disease. J. Med. Virol. 1991, 33:106-113.
63. Goudsmit J., Wolters E.C., Bakker M., Smit L., Van der Noordaa J., Hische E.A., et al. Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex. Br. Med. J. (Clin. Res. Ed.) 1986, 292:1231-1234.
64. Goudsmit J., Epstein L.G., Paul D.A., van der Helm H.J., Dawson G.J., Asher D.M., et al. Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:3876-3880.
65. Gray F., Lescs M.C., Keohane C., Paraire F., Marc B., Durigon M., et al. Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non-AIDS cases. J. Neuropathol. Exp. Neurol. 1992, 51:177-185.
66. Gray F., Scaravilli F., Everall I., Chretien F., An S., Boche D., et al. Neuropathology of early HIV-1 infection. Brain Pathol. 1996, 6:1-15.
67. Gray F., Lescure F.X., Adle-Biassette H., Polivka M., Gallien S., Pialoux G., et al. Encephalitis with infiltration by CD8+ lymphocytes in HIV patients receiving combination antiretroviral treatment. Brain Pathol. 2013, 23:525-533.
68. Greve B., Magnusson C.G., Melms A., Weissert R. Immunoglobulin isotypes reveal a predominant role of type 1 immunity in multiple sclerosis. J. Neuroimmunol. 2001, 121:120-125.
69. Grimaldi L.M., Castagna A., Lazzarin A., Pristera R., Bianchi G., Moroni M., et al. Oligoclonal IgG bands in cerebrospinal fluid and serum during asymptomatic human immunodeficiency virus infection. Ann. Neurol. 1988, 24:277-279.
70. Grimaldi L.M., Castagna A., Maimone D., Martino G.V., Dolci A., Pristera R., et al. Kappa light chain predominance in serum and cerebrospinal fluid from human immunodeficiency virus type 1 (HIV-1)-infected patients. J. Neuroimmunol. 1991, 32:259-268.
71. Hagberg L., Norkrans G., Andersson M., Wachter H., Fuchs D. Cerebrospinal fluid neopterin and beta 2-microglobulin levels in neurologically asymptomatic HIV-infected patients before and after initiation of zidovudine treatment. Infection 1992, 20:313-315.
72. Harp C., Lee J., Lambracht-Washington D., Cameron E., Olsen G., Frohman E., et al. Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection. J. Neuroimmunol. 2007, 183:189-199.
73. Harrington P.R., Haas D.W., Ritola K., Swanstrom R. Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells. J. Virol. 2005, 79:7959-7966.
74. Hassine D., Gray F., Chekroun R., Chretien F., Marc B., Durigon M., et al. Early cerebral lesions in HIV infection. Postmortem radio-pathologic correlations in non-AIDS asymptomatic seropositive patients. J. Neuroradiol. 1995, 22:148-160.
75. Haugen M., Frederiksen J.L., Degn M. B cell follicle-like structures in multiple sclerosis-with focus on the role of B cell activating factor. J. Neuroimmunol. 2014, 273:1-7.
76. Heaton R.K., Clifford D.B., Franklin D.R., Woods S.P., Ake C., Vaida F., et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology 2010, 75:2087-2096.
77. Hill J., Rom S., Ramirez S.H., Persidsky Y. Emerging roles of pericytes in the regulation of the neurovascular unit in health and disease. J. Neuroimmune Pharmacol. 2014, 9:591-605.
78. Hong S., Banks W.A. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications. Brain Behav. Immun. 2015, 45:1-12.
79. Humby F., Bombardieri M., Manzo A., Kelly S., Blades M.C., Kirkham B., et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 2009, 6:e1.
80. Jacobi C., Lange P., Reiber H. Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: discrimination between microorganism-driven and polyspecific immune response. J. Neuroimmunol. 2007, 187:139-146.
81. Jarius S., Eichhorn P., Jacobi C., Wildemann B., Wick M., Voltz R. The intrathecal, polyspecific antiviral immune response: specific for MS or a general marker of CNS autoimmunity?. J. Neurol. Sci. 2009, 280:98-100.
82. Jessen Krut J., Mellberg T., Price R.W., Hagberg L., Fuchs D., Rosengren L., et al. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients. PLoS One 2014, 9:e88591.
83. Kaiser R., Dorries R., Luer W., Poser S., Pohle H.D., Felgenhauer K., et al. Analysis of oligoclonal antibody bands against individual HIV structural proteins in the CSF of patients infected with HIV. J. Neurol. 1989, 236:157-160.
84. Kaiser R., Dorries R., ter Meulen J., Kidenya J.J., Pollath M., Fleischer K., et al. Serologic evidence of human immunodeficiency virus infection of the central nervous system in African patients with acquired immunodeficiency syndrome. Eur. Neurol. 1990, 30:27-31.
85. Kallianpur K.J., Kirk G.R., Sailasuta N., Valcour V., Shiramizu B., Nakamoto B.K., et al. Regional cortical thinning associated with detectable levels of HIV DNA. Cereb. Cortex 2012, 22:2065-2075.
86. Kallianpur K.J., Shikuma C., Kirk G.R., Shiramizu B., Valcour V., Chow D., et al. Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter. Neurology 2013, 80:1792-1799.
87. Kobayashi K., Seilhan D., Uchiara T., Duyckaerts C., Hauw J. High densities of tumor necrosis factor-a in the cerebral cortex and basal ganglia in human immunodeficiency virus-1-associated cognitive/motor complex: a quantitative regional analysis study. Neuropathology 1997, 17:168-173.
88. Koenig S., Gendelman H.E., Orenstein J.M., Dal Canto M.C., Pezeshkpour G.H., Yungbluth M., et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986, 233:1089-1093.
89. Kolb S.A., Sporer B., Lahrtz F., Koedel U., Pfister H.W., Fontana A. Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. J. Neuroimmunol. 1999, 93:172-181.
90. Konstantinopoulos P.A., Dezube B.J., Pantanowitz L., Horowitz G.L., Beckwith B.A. Protein electrophoresis and immunoglobulin analysis in HIV-infected patients. Am. J. Clin. Pathol. 2007, 128:596-603.
91. Lackner P., Kuenz B., Reindl M., Morandell M., Berger T., Schmutzhard E., et al. Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study. J. Neuroinflammation 2010, 7:79.
92. Lambin P., Gervais A., Levy M., Defendini E., Dubarry M., Lebon P., et al. Intrathecal synthesis of IgG subclasses in multiple sclerosis and in acquired immunodeficiency syndrome (AIDS). J. Neuroimmunol. 1991, 35:179-189.
93. Laurijssens M., Heyman P., Gillis C., De Schrijver L., Roggeman D. Oligoclonal immunoglobulins: a possible index of B cell lymphoma in AIDS. Eur. J. Cancer 1993, 29:S45.
94. Lifter J., Kincade P.W., Choi Y.S. Subpopulations of chicken B lymphocytes. J. Immunol. 1976, 117:2220-2225.
95. Lin W.L., Fincke J.E., Sharer L.R., Monos D.S., Lu S., Gaughan J., et al. Oligoclonal T cells are infiltrating the brains of children with AIDS: sequence analysis reveals high proportions of identical beta-chain T-cell receptor transcripts. Clin. Exp. Immunol. 2005, 141:338-356.
96. Lloyd A., Wakefield D., Robertson P., Dwyer J.M. Antibodies to HIV are produced within the central nervous system of all subjects with all categories of HIV infection. Aust. N. Z. J. Med. 1988, 18:854-860.
97. Lolli F., Colao M.G., De Maio E., Di Pietro M., Galli E., Grippo A., et al. Intrathecal synthesis of anti-HIV antibodies in AIDS patients. J. Neurol. Sci. 1990, 99:281-289.
98. Lucey D.R., McGuire S.A., Clerici M., Hall K., Benton J., Butzin C.A., et al. Comparison of spinal fluid beta 2-microglobulin levels with CD4+ T cell count, in vitro T helper cell function, and spinal fluid IgG parameters in 163 neurologically normal adults infected with the human immunodeficiency virus type 1. J. Infect. Dis. 1991, 163:971-975.
99. Margolin D.H., Saunders E.H., Bronfin B., de Rosa N., Axthelm M.K., Goloubeva O.G., et al. Germinal center function in the spleen during simian HIV infection in rhesus monkeys. J. Immunol. 2006, 177:1108-1119.
100. Marra C.M., Tantalo L.C., Sahi S.K., Maxwell C.L., Lukehart S.A. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis. Sex. Transm. Dis. 2010, 37:283-287.
101. Marshall D.W., Brey R.L., Cahill W.T., Houk R.W., Zajac R.A., Boswell R.N. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch. Neurol. 1988, 45:954-958.
102. Marshall D.W., Brey R.L., Butzin C.A. Lack of cerebrospinal fluid myelin basic protein in HIV-infected asymptomatic individuals with intrathecal synthesis of IgG. Neurology 1989, 39:1127-1129.
103. Martin-Blondel G., Delobel P., Blancher A., Massip P., Marchou B., Liblau R.S., et al. Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV. Brain 2011, 134:928-946.
104. Mathiesen T., Sonnerborg A., von Sydow M., Gaines H., Wahren B. IgG subclass reactivity against human immunodeficiency virus (HIV) and cytomegalovirus in cerebrospinal fluid and serum from HIV-infected patients. J. Med. Virol. 1988, 25:17-26.
105. Mathiesen T., Sonnerborg A., von Sydow M., Gaines H., Wahren B. IgG subclasses reactivity against HIV and CMV in CSF and serum from HIV patients. J. Med. Virol. 1988, 25:17-26.
106. Mathiesen T., Sonnerborg A., Wahren B. Detection of antibodies against myelin basic protein and increased levels of HIV-IgG antibodies and HIV antigen after solubilization of immune complexes in sera and CSF of HIV infected patients. Viral Immunol. 1989, 2:1-9.
107. McArthur J.C., Cohen B.A., Selnes O.A., Kumar A.J., Cooper K., McArthur J.H., et al. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the multicenter AIDS cohort study. Ann. Neurol. 1989, 26:601-611.
108. McCrossan M., Marsden M., Carnie F.W., Minnis S., Hansoti B., Anthony I.C., et al. An immune control model for viral replication in the CNS during presymptomatic HIV infection. Brain 2006, 129:503-516.
109. Mecha M., Carrillo-Salinas F.J., Mestre L., Feliu A., Guaza C. Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus. Prog. Neurobiol. 2013, 101-102:46-64.
110. Meira C.S., Vidal J.E., Costa-Silva T.A., Motoie G., Gava R., Hiramoto R.M., et al. IgG4 specific to Toxoplasma gondii excretory/secretory antigens in serum and/or cerebrospinal fluid support the cerebral toxoplasmosis diagnosis in HIV-infected patients. J. Immunol. Methods 2013, 395:21-28.
111. Mellgren A., Price R.W., Hagberg L., Rosengren L., Brew B.J., Gisslen M. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection. Neurology 2007, 69:1536-1541.
112. Milush J.M., Chen H.L., Atteberry G., Sodora D.L. Early detection of simian immunodeficiency virus in the central nervous system following oral administration to rhesus macaques. Front. Immunol. 2013, 4:236.
113. Mokhtarian F., Huan C.M., Roman C., Raine C.S. Semliki Forest virus-induced demyelination and remyelination-involvement of B cells and anti-myelin antibodies. J. Neuroimmunol. 2003, 137:19-31.
114. Moll N.M., Rietsch A.M., RansohoffA.J., Cossoy M.B., Huang D., Eichler F.S., et al. Cortical demyelination in PML and MS: similarities and differences. Neurology 2008, 70:336-343.
115. Neyt K., Perros F., GeurtsvanKessel C.H., Hammad H., Lambrecht B.N. Tertiary lymphoid organs in infection and autoimmunity. Trends Immunol. 2012, 33:297-305.
116. Otto C., Hofmann J., Finke C., Zimmermann M., Ruprecht K. The fraction of varicella zoster virus-specific antibodies among all intrathecally-produced antibodies discriminates between patients with varicella zoster virus reactivation and multiple sclerosis. Fluids Barriers CNS 2014, 11:3.
117. Owens G.P., Bennett J.L., Lassmann H., O'Connor K.C., Ritchie A.M., Shearer A., et al. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann. Neurol. 2009, 65:639-649.
118. Owens G.P., Gilden D., Burgoon M.P., Yu X., Bennett J.L. Viruses and multiple sclerosis. Neuroscientist 2011, 17:659-676.
119. Peluso M.J., Ferretti F., Peterson J., Lee E., Fuchs D., Boschini A., et al. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS 2012, 26:1765-1774.
120. Petito C.K., Adkins B., McCarthy M., Roberts B., Khamis I. CD4+ and CD8+ cells accumulate in the brains of acquired immunodeficiency syndrome patients with human immunodeficiency virus encephalitis. J. Neurovirol. 2003, 9:36-44.
121. Petito C.K., Torres-Munoz J.E., Zielger F., McCarthy M. Brain CD8+ and cytotoxic T lymphocytes are associated with, and may be specific for, human immunodeficiency virus type 1 encephalitis in patients with acquired immunodeficiency syndrome. J. Neurovirol. 2006, 12:272-283.
122. Potasman I., Resnick L., Luft B.J., Remington J.S. Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 1988, 108:49-51.
123. Probasco J.C., Deeks S.G., Lee E., Hoh R., Hunt P.W., Liegler T., et al. Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammation. AIDS 2010, 24:1001-1005.
124. Ragin A.B., Du H., Ochs R., Wu Y., Sammet C.L., Shoukry A., et al. Structural brain alterations can be detected early in HIV infection. Neurology 2012, 79:2328-2334.
125. Reiber H., Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin. Chem. 1991, 37:1153-1160.
126. Reiber H., Peter J.B. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J. Neurol. Sci. 2001, 184:101-122.
127. Reiber H., Teut M., Pohl D., Rostasy K.M., Hanefeld F. Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid. Mult. Scler. 2009, 15:1466-1480.
128. Resnick L., diMarzo-Veronese F., Schupbach J., Tourtellotte W.W., Ho D.D., Muller F., et al. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N. Engl. J. Med. 1985, 313:1498-1504.
129. Rodriguez S.K., Sarr A.D., Olorunnipa O., Popper S.J., Gueye-Ndiaye A., Traore I., et al. The absence of anti-Tat antibodies is associated with risk of disease progression in HIV-2 infection. J. Infect. Dis. 2006, 194:760-763.
130. Saha R.N., Pahan K. Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia. J. Neurochem. 2003, 86:1057-1071.
131. Sas A.R., Bimonte-Nelson H.A., Tyor W.R. Cognitive dysfunction in HIV encephalitic SCID mice correlates with levels of interferon-alpha in the brain. AIDS 2007, 21:2151-2159.
132. Schnell G., Spudich S., Harrington P., Price R.W., Swanstrom R. Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia. PLoS Pathog. 2009, 5:e1000395.
133. Schuh C., Wimmer I., Hametner S., Haider L., Van Dam A.M., Liblau R.S., et al. Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models. Acta Neuropathol. 2014, 128:247-266.
134. Schwender S., Imrich H., Dorries R. The pathogenic role of virus-specific antibody-secreting cells in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis. Immunology 1991, 74:533-538.
135. Seilhean D., Kobayashi K., He Y., Uchihara T., Rosenblum O., Katlama C., et al. Tumor necrosis factor-alpha, microglia and astrocytes in AIDS dementia complex. Acta Neuropathol. 1997, 93:508-517.
136. Simioni S., Cavassini M., Annoni J.M., Rimbault Abraham A., Bourquin I., Schiffer V., et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 2010, 24:1243-1250.
137. Simioni S., Cavassini M., Annoni J.M., Hirschel B., Du Pasquier R.A. HIV-associated neurocognitive disorders: a changing pattern. Future Neurol. 2011, 6:81-95.
138. Singer E.J., Syndulko K., Fahy-Chandon B.N., Shapshak P., Resnick L., Schmid P., et al. Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1. AIDS 1994, 8:197-204.
139. Smit T.K., Brew B.J., Tourtellotte W., Morgello S., Gelman B.B., Saksena N.K. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. J. Virol. 2004, 78:10133-10148.
140. Smith M.O., Sutjipto S., Lackner A.A. Intrathecal synthesis of IgG in simian immunodeficiency virus (SIV)-infected rhesus macaques (Macaca mulatta). AIDS Res. Hum. Retrovir. 1994, 10:81-89.
141. Smith M.O., Heyes M.P., Lackner A.A. Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus. Lab. Invest. 1995, 72:547-558.
142. Sonnerborg A.B., von Sydow M.A., Forsgren M., Strannegard O.O. Association between intrathecal anti-HIV-1 immunoglobulin G synthesis and occurrence of HIV-1 in cerebrospinal fluid. AIDS 1989, 3:701-705.
143. Sopper S., Sauer U., Hemm S., Demuth M., Muller J., Stahl-Hennig C., et al. Protective role of the virus-specific immune response for development of severe neurologic signs in simian immunodeficiency virus-infected macaques. J. Virol. 1998, 72:9940-9947.
144. Spudich S.S., Ances B.M. Central nervous system complications of HIV infection. Top Antivir. Med. 2011, 19:48-57.
145. Spudich S.S., Nilsson A.C., Lollo N.D., Liegler T.J., Petropoulos C.J., Deeks S.G., et al. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect. Dis. 2005, 5:98.
146. Stam A.J., Nijhuis M., van den Bergh W.M., Wensing A.M. Differential genotypic evolution of HIV-1 quasispecies in cerebrospinal fluid and plasma: a systematic review. AIDS Rev. 2013, 15:152-161.
147. Subak-Sharpe I., Dyson H., Fazakerley J. In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection. J. Virol. 1993, 67:7629-7633.
148. Tavazzi E., Morrison D., Sullivan P., Morgello S., Fischer T. Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection. Curr. HIV Res. 2014, 12:97-110.
149. Tourtellotte W.W., Baumhefner R.W., Potvin A.R., Ma B.I., Potvin J.H., Mendez M., et al. Multiple sclerosis de novo CNS IgG synthesis: effect of ACTH and corticosteroids. Neurology 1980, 30:1155-1162.
150. Towgood K.J., Pitkanen M., Kulasegaram R., Fradera A., Kumar A., Soni S., et al. Mapping the brain in younger and older asymptomatic HIV-1 men: frontal volume changes in the absence of other cortical or diffusion tensor abnormalities. Cortex 2012, 48:230-241.
151. Tyor W.R., Glass J.D., Baumrind N., McArthur J.C., Griffin J.W., Becker P.S., et al. Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology 1993, 43:1002-1009.
152. Van Wielink G., McArthur J.C., Moench T., Farzadegan H., McArthur J.H., Johnson R.T., et al. Intrathecal synthesis of anti-HIV IgG: correlation with increasing duration of HIV-1 infection. Neurology 1990, 40:816-819.
153. von Budingen H.C., Kuo T.C., Sirota M., van Belle C.J., Apeltsin L., Glanville J., et al. B cell exchange across the blood-brain barrier in multiple sclerosis. J. Clin. Invest. 2012, 122:4533-4543.
154. Warnke C., Stettner M., Lehmensiek V., Dehmel T., Mausberg A.K., von Geldern G., et al. Natalizumab Exerts a Suppressive Effect on Surrogates of B Cell Function in Blood and CSF. Mult. Scler. 2014, (Epub ahead of print).
155. Weber T., Beck R., Stark E., Gerhards J., Korn K., Haas J., et al. Comparative analysis of intrathecal antibody synthesis and DNA amplification for the diagnosis of cytomegalovirus infection of the central nervous system in AIDS patients. J. Neurol. 1994, 241:407-414.
156. Wildemann B., Oschmann P., Reiber H. Laboratory Diagnosis in Neurology 2010, Thieme, Stuttgart; New York.
157. Winges K.M., Gilden D.H., Bennett J.L., Yu X., Ritchie A.M., Owens G.P. Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts. J. Neuroimmunol. 2007, 192:226-234.
158. Yilmaz A., Fuchs D., Hagberg L., Nillroth U., Stahle L., Svensson J.O., et al. Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study. BMC Infect. Dis. 2006, 6:63.
159. Yilmaz A., Price R.W., Spudich S., Fuchs D., Hagberg L., Gisslen M. Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2008, 47:168-173.
160. Yilmaz A., Yiannoutsos C.T., Fuchs D., Price R.W., Crozier K., Hagberg L., et al. Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy. J. Neuroinflammation 2013, 10:62.